What’s interesting about the early phase?
What are the typical decisions for phase II?
Speaking about a new indication, how are decisions being taken across the industry?
How should we think about phase II studies in this setting?
What statistical approaches do we have to formulate this thinking?
In this episode, Trevor Smart and I discuss a case study to go through the step by step procedure of phase II.
We also talk about the following points:
- What are decision rules?
- How can we use prior elicitation?
- What and how do you come to a prior distribution and what is a design prior?
- What role do relevant and non-relevant differences play here?
- Any recommended reading?
- What you can do differently to make sure, we make better decisions in phase II?
Listen to this episode and become an effective statistician!
Never miss an episode!
Join thousends of your peers and subscribe to get our latest updates by email!
Get the
Learn on demand
Click on the button to see our Teachble Inc. cources.
Featured courses
Click on the button to see our Teachble Inc. cources.
Join The Effective Statistician LinkedIn group
This group was set up to help each other to become more effective statisticians. We’ll run challenges in this group, e.g. around writing abstracts for conferences or other projects. I’ll also post into this group further content.
I want to help the community of statisticians, data scientists, programmers and other quantitative scientists to be more influential, innovative, and effective. I believe that as a community we can help our research, our regulatory and payer systems, and ultimately physicians and patients take better decisions based on better evidence.
I work to achieve a future in which everyone can access the right evidence in the right format at the right time to make sound decisions.
When my kids are sick, I want to have good evidence to discuss with the physician about the different therapy choices.
When my mother is sick, I want her to understand the evidence and being able to understand it.
When I get sick, I want to find evidence that I can trust and that helps me to have meaningful discussions with my healthcare professionals.
I want to live in a world, where the media reports correctly about medical evidence and in which society distinguishes between fake evidence and real evidence.
Let’s work together to achieve this.
